ArticleBiomedical reports2025

Therapeutic potential of a systemically applied humanized monoclonal antibody targeting Toll‑like receptor 2 in atopic‑dermatitis‑like skin lesions in a mouse model.

Hyunjin Yeo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.